{"id":"https://openalex.org/W2018449488","doi":"https://doi.org/10.1046/j.1365-3083.2001.00832.x","title":"Alteration in CD29high CD4+ Lymphocyte Subset is a Common Feature of Early HIV Disease and of Active Tuberculosis","display_name":"Alteration in CD29high CD4+ Lymphocyte Subset is a Common Feature of Early HIV Disease and of Active Tuberculosis","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W2018449488","doi":"https://doi.org/10.1046/j.1365-3083.2001.00832.x","mag":"2018449488","pmid":"https://pubmed.ncbi.nlm.nih.gov/11169210"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-3083.2001.00832.x","doi":"https://doi.org/10.1046/j.1365-3083.2001.00832.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-3083.2001.00832.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-3083.2001.00832.x","source":{"id":"https://openalex.org/S79173686","display_name":"Scandinavian Journal of Immunology","issn_l":"0300-9475","issn":["0300-9475","1365-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-3083.2001.00832.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006217440","display_name":"Serge P. Diagbouga","orcid":"https://orcid.org/0000-0003-0920-1725","observed_orcids":["https://orcid.org/0000-0003-0920-1725"]},"institutions":[{"id":"https://openalex.org/I4210156996","display_name":"Centre Muraz","ror":"https://ror.org/04nhm0g90","country_code":"BF","type":"other","lineage":["https://openalex.org/I4210156996"]}],"countries":["BF"],"is_corresponding":true,"raw_author_name":"S. Diagbouga","raw_affiliation_strings":["Centre Muraz, Organisation de Coordination et de Coop\u00e9ration pour la lutte contre les Grandes End\u00e9mies, Burkina Faso, West Africa. diagbouga_serge@hotmail.com","Centre Muraz, Organisation de Coordination et de Coop\u00e9ration pour la lutte contre les Grandes End\u00e9mies (O.C.C.G.E.), Burkina Faso, West Africa;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Muraz, Organisation de Coordination et de Coop\u00e9ration pour la lutte contre les Grandes End\u00e9mies, Burkina Faso, West Africa. diagbouga_serge@hotmail.com","institution_ids":["https://openalex.org/I4210156996"]},{"raw_affiliation_string":"Centre Muraz, Organisation de Coordination et de Coop\u00e9ration pour la lutte contre les Grandes End\u00e9mies (O.C.C.G.E.), Burkina Faso, West Africa;","institution_ids":["https://openalex.org/I4210156996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111952253","display_name":"J.P. Chiron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I110017253","display_name":"Universit\u00e9 de Tours","ror":"https://ror.org/02wwzvj46","country_code":"FR","type":"education","lineage":["https://openalex.org/I110017253"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.\u2010P. Chiron","raw_affiliation_strings":["present address: Laboratoire de Microbiologie-Immunologie, Faculte\u0301 des Sciences Pharmaceutiques Philippe Maupas, Tours, France; and","present address: Laboratoire de Microbiologie\u2010Immunologie, Facult\u00e9 des Sciences Pharmaceutiques Philippe Maupas, Tours, France; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"present address: Laboratoire de Microbiologie-Immunologie, Faculte\u0301 des Sciences Pharmaceutiques Philippe Maupas, Tours, France; and","institution_ids":["https://openalex.org/I110017253"]},{"raw_affiliation_string":"present address: Laboratoire de Microbiologie\u2010Immunologie, Facult\u00e9 des Sciences Pharmaceutiques Philippe Maupas, Tours, France; and","institution_ids":["https://openalex.org/I110017253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074204802","display_name":"Oumarou Sanou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156996","display_name":"Centre Muraz","ror":"https://ror.org/04nhm0g90","country_code":"BF","type":"other","lineage":["https://openalex.org/I4210156996"]}],"countries":["BF"],"is_corresponding":false,"raw_author_name":"O. Sanou","raw_affiliation_strings":["Centre Muraz, Organisation de Coordination et de Coope\u0301ration pour la lutte contre les Grandes Ende\u0301mies (O.C.C.G.E.), Burkina Faso, West Africa;","Centre Muraz, Organisation de Coordination et de Coop\u00e9ration pour la lutte contre les Grandes End\u00e9mies (O.C.C.G.E.), Burkina Faso, West Africa;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Muraz, Organisation de Coordination et de Coope\u0301ration pour la lutte contre les Grandes Ende\u0301mies (O.C.C.G.E.), Burkina Faso, West Africa;","institution_ids":["https://openalex.org/I4210156996"]},{"raw_affiliation_string":"Centre Muraz, Organisation de Coordination et de Coop\u00e9ration pour la lutte contre les Grandes End\u00e9mies (O.C.C.G.E.), Burkina Faso, West Africa;","institution_ids":["https://openalex.org/I4210156996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041828016","display_name":"\u00c9ric Ledru","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157536573","display_name":"Institut Pasteur","ror":"https://ror.org/0495fxg12","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I157536573"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Ledru","raw_affiliation_strings":["Institut Pasteur, Unite\u0301 d'Oncologie Virale, Paris, France","Institut Pasteur, Unit\u00e9 d'Oncologie Virale, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Pasteur, Unite\u0301 d'Oncologie Virale, Paris, France","institution_ids":["https://openalex.org/I157536573"]},{"raw_affiliation_string":"Institut Pasteur, Unit\u00e9 d'Oncologie Virale, Paris, France","institution_ids":["https://openalex.org/I157536573"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5006217440"],"corresponding_institution_ids":["https://openalex.org/I4210156996"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.08590853,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"53","issue":"1","first_page":"79","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.5845000147819519,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.5845000147819519,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.3582000136375427,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.02630000002682209,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd4-t-cell-depletion","display_name":"CD4+ T cell depletion","score":0.7929999828338623},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.6359999775886536},{"id":"https://openalex.org/keywords/pulmonary-tuberculosis","display_name":"pulmonary tuberculosis","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hiv-tb-co-infection","display_name":"HIV/TB coinfection","score":0.847000002861023},{"id":"https://openalex.org/keywords/t-cell-homeostasis","display_name":"T cell homeostasis","score":0.8920000195503235},{"id":"https://openalex.org/keywords/mycobacterium-tuberculosis","display_name":"Mycobacterium tuberculosis","score":0.9049999713897705}],"concepts":[{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.7855396866798401},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5913174152374268},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5474954843521118},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5171877145767212},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.515112578868866},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.44014471769332886},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4140353500843048},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.17406097054481506},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11859026551246643}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002050","descriptor_name":"Burkina Faso","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006706","descriptor_name":"Homeostasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015704","descriptor_name":"CD4 Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017493","descriptor_name":"Leukocyte Common Antigens","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019012","descriptor_name":"Integrin beta1","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-3083.2001.00832.x","doi":"https://doi.org/10.1046/j.1365-3083.2001.00832.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-3083.2001.00832.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-3083.2001.00832.x","source":{"id":"https://openalex.org/S79173686","display_name":"Scandinavian Journal of Immunology","issn_l":"0300-9475","issn":["0300-9475","1365-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:11169210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11169210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian journal of immunology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1046/j.1365-3083.2001.00832.x","doi":"https://doi.org/10.1046/j.1365-3083.2001.00832.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-3083.2001.00832.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-3083.2001.00832.x","source":{"id":"https://openalex.org/S79173686","display_name":"Scandinavian Journal of Immunology","issn_l":"0300-9475","issn":["0300-9475","1365-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Journal of Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2018449488.pdf","grobid_xml":"https://content.openalex.org/works/W2018449488.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W55625018","https://openalex.org/W110517169","https://openalex.org/W199133722","https://openalex.org/W1580217007","https://openalex.org/W1588713146","https://openalex.org/W1593599243","https://openalex.org/W1877478601","https://openalex.org/W1929705279","https://openalex.org/W1965530279","https://openalex.org/W1975159750","https://openalex.org/W1978141065","https://openalex.org/W1980667816","https://openalex.org/W1982976321","https://openalex.org/W1986097902","https://openalex.org/W2000620558","https://openalex.org/W2002311722","https://openalex.org/W2004694654","https://openalex.org/W2009825356","https://openalex.org/W2029777784","https://openalex.org/W2033607574","https://openalex.org/W2034029016","https://openalex.org/W2057150185","https://openalex.org/W2058419095","https://openalex.org/W2086763790","https://openalex.org/W2093044736","https://openalex.org/W2127059220","https://openalex.org/W2132136467","https://openalex.org/W2148837825","https://openalex.org/W2155782151","https://openalex.org/W2161415222","https://openalex.org/W2163345314","https://openalex.org/W2163349584","https://openalex.org/W2274232185","https://openalex.org/W2312692451","https://openalex.org/W2410179385","https://openalex.org/W2439643061","https://openalex.org/W4249756873","https://openalex.org/W4299411399","https://openalex.org/W4300561794"],"related_works":["https://openalex.org/W4391914909","https://openalex.org/W2056973387","https://openalex.org/W4232388187","https://openalex.org/W1857104263","https://openalex.org/W2000620558","https://openalex.org/W2607663876","https://openalex.org/W2288310659","https://openalex.org/W2040449073","https://openalex.org/W1501932791","https://openalex.org/W2074758159"],"abstract_inverted_index":{"Peripheral":[0],"CD4":[1,30],"T-cell":[2,124,139],"depletion":[3,140],"has":[4],"been":[5],"observed":[6,65,141],"in":[7,32,55,66,71,99,113,121,128],"human":[8],"immunodeficiency":[9],"virus":[10],"(HIV)-negative":[11],"patients":[12,35,45,103,115],"with":[13,36],"pulmonary":[14],"tuberculosis":[15,170],"(TB).":[16],"To":[17],"investigate":[18],"more":[19],"accurately":[20],"this":[21],"alteration,":[22],"we":[23],"studied":[24],"peripheral":[25],"blood":[26],"CD45RA(+)":[27,76],"and":[28,49,89,101],"CD29(high)":[29],"subsets":[31],"79":[33],"TB":[34,47,114],"(HIV(+)TB(+))":[37],"or":[38],"without":[39,46,116],"(HIV(-)TB(+))":[40],"HIV":[41,145],"infection,":[42],"85":[43],"HIV-infected":[44,131],"(HIV(+)TB(-)),":[48],"43":[50],"healthy":[51],"controls,":[52,105],"all":[53],"living":[54],"West":[56],"Africa.":[57],"The":[58],"high":[59],"proportion":[60],"of":[61,93,151,158,167],"CD4(+)CD29(high)":[62],"T":[63,78,95,108,159],"cells":[64,79,96,109,160],"controls":[67],"was":[68],"dramatically":[69],"decreased":[70,98,112],"CDC-A":[72],"stage":[73],"HIV(+)TB(-)":[74],"patients.":[75],"CD4(+)":[77,123],"were":[80,97,110],"depleted":[81],"during":[82,142],"the":[83,87,90,122,137,143,149,156,165,168],"CDC-B":[84],"stage.":[85],"Both":[86],"percentage":[88],"absolute":[91],"count":[92],"CD29(high)CD4(+)":[94],"HIV(-)TB(+)":[100],"HIV(+)TB(+)":[102],"versus":[104,130],"but":[106],"CD45RA(+)CD4(+)":[107],"not":[111],"HIV-infection.":[117],"Although":[118],"distinct":[119],"alterations":[120],"homeostasis":[125],"are":[126],"involved":[127],"TB(-)":[129],"subjects,":[132],"our":[133],"data":[134],"suggest":[135],"that":[136],"CD29(+)CD4(+)":[138],"early":[144],"disease":[146],"contributes":[147],"to":[148,162,164],"risk":[150],"active":[152],"TB,":[153],"by":[154],"reducing":[155],"pool":[157],"able":[161],"relocalize":[163],"sites":[166],"M.":[169],"multiplication.":[171]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}